Sanofi: information concerning the total number of voting rights and shares, December 2019

  Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,504,039,842 € Registered office : 54, rue La Boétie – 75008 Paris – France Registered at the Paris Commercial and...
Comunicato Precedente

next
Comunicato Successivo

next
Paris, (informazione.it - comunicati stampa - salute e benessere)

  

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l'Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi
a French société anonyme with a registered share capital of 2,504,039,842 €
Registered office : 54, rue La Boétie – 75008 Paris – France
Registered at the Paris Commercial and Companies Registry under number 395 030 844

Date  

Total number of
issued shares


 
Number of real
voting rights
(excluding treasury shares)
Theoretical number of
voting rights
(including treasury shares)*
December 31, 2019 1,253,846,111  

1,406,203,455

 
 

1,406,222,936

 

*  Pursuant to article 223-11 of the Règlement général de l'Autorité des Marchés Financiers.

This information is also available on the internet website of sanofi under « Regulated Information in France »:https://www.sanofi.com/en/investors/sanofi-share-and-adrs/share-overview/shares-and-voting-rights/

Investor Relations Department
Europe Tel: + 33 1 53 77 45 45  US Tel: + 1 908 981 5560
e-mail: [email protected]

 

Media Relations Department
Tel: + 33 1 53 77 46 46
 e-mail: [email protected]

 

 

Attachment

  • EN_number_of_shares_and_voting_rights_December_2019
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Slide ShowSlide Show
Non disponibili